Synopsys Posts Financial Results for Third Quarter Fiscal Year 2024

 

SYNOPSYS, INC.

 

Unaudited Condensed Consolidated Balance Sheets (1)

 

(in thousands, except par value amounts)

 
       
 

July 31, 2024

October 31, 2023

 

ASSETS:

     

Current assets:

     

  Cash and cash equivalents

$           1,839,815

$           1,433,966

 

  Short-term investments

154,431

151,639

 

          Total cash, cash equivalents and short-term investments

1,994,246

1,585,605

 

  Accounts receivable, net

805,198

856,660

 

  Inventories

386,009

325,590

 

  Prepaid and other current assets

914,598

548,115

 

  Current assets held for sale

1,027,702

114,654

 

          Total current assets

5,127,753

3,430,624

 

Property and equipment, net

571,408

549,837

 

Operating lease right-of-use assets, net

556,593

559,923

 

Goodwill

3,444,349

3,346,065

 

Intangible assets, net

266,092

239,577

 

Deferred income taxes

1,102,716

853,526

 

Other long-term assets

579,773

444,820

 

Long-term assets held for sale

908,759

 

           Total assets

$         11,648,684

$         10,333,131

 
       

LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND
STOCKHOLDERS' EQUITY:

     

Current liabilities:

     

  Accounts payable and accrued liabilities

$              756,983

$           1,059,914

 

  Operating lease liabilities

89,869

79,832

 

  Deferred revenue

1,356,804

1,559,461

 

  Current liabilities held for sale

331,294

286,244

 

           Total current liabilities

2,534,950

2,985,451

 

Long-term operating lease liabilities

568,407

579,686

 

Long-term deferred revenue

319,080

150,827

 

Long-term debt

15,599

18,078

 

Other long-term liabilities

465,233

381,531

 

Long-term liabilities held for sale

33,257

 

           Total liabilities

3,903,269

4,148,830

 

Redeemable non-controlling interest

31,043

31,043

 

Stockholders' equity:

     

  Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

 

  Common stock, $0.01 par value: 400,000 shares authorized; 153,613 and
152,053 shares outstanding, respectively

1,536

1,521

 

  Capital in excess of par value

1,192,363

1,276,152

 

  Retained earnings

7,884,044

6,741,699

 

  Treasury stock, at cost: 3,648 and 5,207 shares, respectively

(1,188,435)

(1,675,650)

 

  Accumulated other comprehensive income (loss)

(180,112)

(196,414)

 

           Total Synopsys stockholders' equity

7,709,396

6,147,308

 

Non-controlling interest

4,976

5,950

 

           Total stockholders' equity

7,714,372

6,153,258

 

           Total liabilities, redeemable non-controlling interest and stockholders' equity

$         11,648,684

$         10,333,131

 
       

(1) Synopsys' third quarter of fiscal year 2024 ended on August 3, 2024 and its fiscal year 2023 ended on October 28, 2023,
respectively. For presentation purposes, we refer to the closest calendar month end. The first quarter of fiscal year 2024
included one extra week.

 
   

« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8  Next Page »



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise